Center for Thoracic Cancer Care

When it comes to lung and tho­racic can­cers, ear­ly detec­tion, pre­ci­sion treat­ment, and ongo­ing sup­port make all the dif­fer­ence. At the Bri­an Moran Can­cer Insti­tute, our Tho­racic Oncol­o­gy team brings togeth­er exper­tise, com­pas­sion, and advanced tech­nol­o­gy to deliv­er care that’s fast, coor­di­nat­ed, and designed around you.

Why choose our tho­racic can­cer care

Per­son­al­ized, coor­di­nat­ed care from the start

Your jour­ney begins with a ded­i­cat­ed Tho­racic Oncol­o­gy Nurse Nav­i­ga­tor — your per­son­al point of con­tact through diag­no­sis, treat­ment, and recov­ery. With spe­cial­ized knowl­edge in lung and tho­racic can­cers, your nav­i­ga­tor helps sched­ule appoint­ments, explain test results, and guide you and your fam­i­ly through every step of care.

Our mul­ti­dis­ci­pli­nary team of tho­racic sur­geons, pul­mo­nolo­gists, med­ical and radi­a­tion oncol­o­gists, and inter­ven­tion­al spe­cial­ists col­lab­o­rates close­ly to devel­op your per­son­al­ized plan. We make sure you’re seen quick­ly and have access to the right treat­ments with­out unnec­es­sary delays.

Advanced tech­nol­o­gy and treatments

Our tho­racic pro­gram com­bines inno­va­tion with com­pas­sion to detect and treat can­cer pre­cise­ly and effec­tive­ly. We use the lat­est tools and approach­es, including:

• Low-dose CT (LDCT) lung screen­ing for ear­ly detec­tion in eli­gi­ble patients
• ION robot­ic bron­choscopy for pre­cise, min­i­mal­ly inva­sive lung biop­sy and diagnosis
• Min­i­mal­ly inva­sive and robot­ic-assist­ed tho­racic surgery to short­en recov­ery and pre­serve lung function
• Pre­ci­sion radi­a­tion ther­a­py cus­tomized to the tumor’s shape and movement
• Tar­get­ed and immunother­a­pies guid­ed by bio­mark­er test­ing to match treat­ment to your tumor’s unique profile
• Pre­ci­sion test­ing, includ­ing genet­ic and genom­ic analy­sis through part­ners like Tem­pus, to help guide each treat­ment decision
• Access to clin­i­cal tri­als offer­ing next-gen­er­a­tion treat­ment options close to home

Treat­ments we offer

We treat the full range of tho­racic malig­nan­cies, includ­ing lung can­cer, mesothe­lioma, medi­asti­nal tumors, and chest wall can­cers. Every plan is built around what’s best for you to bal­ance effec­tive­ness, recov­ery, and qual­i­ty of life.

Sur­gi­cal treatments

Our sur­geons per­form min­i­mal­ly inva­sive and robot­ic-assist­ed tho­racic surg­eries to remove tumors while pro­tect­ing healthy tis­sue and pre­serv­ing lung func­tion when­ev­er possible.

Radi­a­tion therapy

We use advanced image-guid­ed and inten­si­ty-mod­u­lat­ed radi­a­tion ther­a­py (IMRT/IGRT) to deliv­er pre­cise, tar­get­ed dos­es that lim­it dam­age to near­by organs.

Sys­temic and tar­get­ed therapies

Your med­ical oncol­o­gist may rec­om­mend chemother­a­py, immunother­a­py, or bio­mark­er-direct­ed tar­get­ed ther­a­py to treat your can­cer through­out the body.

These ther­a­pies are select­ed based on the mol­e­c­u­lar and genom­ic char­ac­ter­is­tics of your tumor — ensur­ing a per­son­al­ized approach for the best pos­si­ble outcome.

Sup­port and recov­ery programs

From the moment you con­nect with our team, you’ll have a net­work of sup­port designed to help you and your loved ones every step of the way.

• Tho­racic Oncol­o­gy Nurse Nav­i­ga­tor: Your ded­i­cat­ed con­tact who coor­di­nates your care, pro­vides edu­ca­tion, and sup­ports you from diag­no­sis through survivorship.
• Oncol­o­gy Reg­is­tered Dietit­ian: Offers guid­ance to main­tain strength, man­age side effects, and sup­port recovery.
• Oncol­o­gy Social Work­er: Helps you and your fam­i­ly nav­i­gate emo­tion­al, prac­ti­cal, and finan­cial challenges.
• Pul­monary reha­bil­i­ta­tion to improve lung strength and endurance before and after treatment.
• Smok­ing ces­sa­tion sup­port and resources for patients ready to quit.

Learn more about our sup­port services >

Clin­i­cal tri­als and research

Clin­i­cal tri­als give eli­gi­ble patients access to inno­v­a­tive ther­a­pies and bio­mark­er-dri­ven treat­ments that may not yet be wide­ly avail­able. Our team will review avail­able tri­als with you and help coor­di­nate par­tic­i­pa­tion when appropriate.

Cur­rent tho­racic and lung can­cer clin­i­cal tri­als and research: 

• NCT07144280 — Bri­an Myre, MD — A Ran­dom­ized, Phase 3, Open-Label Study to Eval­u­ate PF-08046054/S­GN­PDL1V Ver­sus Doc­etax­el in Adult Par­tic­i­pants With Pre­vi­ous­ly-Treat­ed Pro­grammed Cell Death Lig­and 1 (PD-L1) Pos­i­tive Non-Small-Cell Lung Can­cer (NSCLC)
• NCT05468489 — Nafisa Burhani, MD — A Ran­dom­ized, Open-label Study of HLX10 plus Chemother­a­py (Car­bo­platin-Etopo­side) in com­par­i­son with Ate­zolizum­ab plus Chemother­a­py in Pre­vi­ous­ly Untreat­ed US Patients with Exten­sive Stage Small Cell Lung Can­cer (ES-SCLC) 
• NCT06246110 — Nafisa Burhani, MD — A Phase 2 Study of EIK1001 in Com­bi­na­tion with Pem­brolizum­ab and Chemother­a­py in Patients with Stage 4 Non-Small Cell Lung Cancer

Explore our cur­rent clin­i­cal tri­als and research programs >

Screen­ing and prevention

Ear­ly detec­tion saves lives. At Duly, 75% of lung can­cers found through our screen­ing pro­gram are detect­ed at stage 1 or 2, when treat­ment is most effec­tive, and out­comes are best. If you’re at increased risk for lung can­cer, talk with your provider about whether a low-dose CT (LDCT) screen­ing is right for you. Orders can be placed by your pri­ma­ry care provider, pul­mo­nolo­gist, or oncologist.

To sched­ule a lung can­cer screen­ing LDCT, call 630−545−7880.

Learn more about who should be screened for lung cancer > 

How to get started

If you’ve been diag­nosed with a tho­racic can­cer or have an abnor­mal scan, we can see you quick­ly, often with­in a week. Our team will review your records, answer your ques­tions, and cre­ate a care plan that’s focused on you.

Sched­ule an Appoint­ment Online or Call 630−348−3600

If you’re seek­ing a sec­ond opin­ion, bring pri­or imag­ing and reports — we’ll review every­thing and guide you through next steps.